36 ORAL A Phase I single dose escalation study of the novel Polo-like kinase 1 inhibitor BI 6727 in patients with advanced solid tumours
P. Schöffski, A. Awada, H. Dumez, T. Gil, S. Bartholomeus, J. Selleslach, M. Taton, H. Fritsch, N. Peter, G. MunzertVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)71968-2
File:
PDF, 75 KB
english, 2008